SAFINAMIDE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Safinamide Mesylate patents expire, and what generic alternatives are available?
Safinamide Mesylate is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in SAFINAMIDE MESYLATE is safinamide mesylate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the safinamide mesylate profile page.
Summary for SAFINAMIDE MESYLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 29 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SAFINAMIDE MESYLATE |
DailyMed Link: | SAFINAMIDE MESYLATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SAFINAMIDE MESYLATE
US Patents and Regulatory Information for SAFINAMIDE MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | SAFINAMIDE MESYLATE | safinamide mesylate | TABLET;ORAL | 215902-001 | Jun 14, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | SAFINAMIDE MESYLATE | safinamide mesylate | TABLET;ORAL | 215902-002 | Jun 14, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |